home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On How to Prepare Yourself for FDA's on-going Part 11 Inspection Program

 
  October 01, 2015  
     
 


Compliance Trainings, Mississauga
2015-10-13


Description :

FDA continues to enforce Part 11 through its new Part 11 inspection and enforcement program. Just in the last 3 years, FDA issued more than 30 warning letters with Part 11 violations. Citations are related to inadequate integrity, security and availability of electronic records but also related to validation of software and computer systems. There are many questions about the program, e.g., what inspectors are looking at what are major findings. The seminar will have the answers. In addition, using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections.

For easy implementation, attendees will receive three SOPs

Checklist: Part 11 compliance

Case Studies: How to avoid Part 11 related 483's and Warning Letters

SOP:  Electronic Audit trail: Specifications, Implementation, Validation

Areas Covered in the Session :

FDA's current inspection and enforcement practices

FDA's new interpretation: learning from FDA  inspection reports

Strategy for cost-effective implementation of  Part 11: A six step plan

Recommended changes to existing Part 11 programs to reduce costs

Justification and documentation for the FDA and your management

Going through case studies from laboratories, offices and manufacturing with graphical workflow of records, step-by-step description, recommendations for individual Part 11 requirements with justifications and documentation for the FDA and your management.

Case studies how to avoid or respond to Part 11 related observations with corrective actions to fix current issues and preventive actions to prevent reoccurrence of the same or similar issues.

How to prepare your company for Part 11 Inspections

Who Will Benefit:

A must attend webinar for professionals in Small, midsize and large Pharmaceutical companies, API manufacturers, Contract laboratories, Clinical testing laboratories, CROs, Medical device industry. The professionals who will benefit include all:

QC managers

QA managers and personnel

IT administrators

Analysts

Regulatory affairs

Training departments

Documentation department

 

Consultants

 
 
Organized by: Compliance Trainings
Invited Speakers:

Ludwig Huber, Ph.D., is the director of Labcompliance and editor of (www.labcompliance.com), the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11, 21CFR Part 111 and Validation around the world. This included seminars, workshops and presentations for the US FDA, China SFDA, Korea MFDS, Singapore HSA, ISPE, Japan PDA, PIC/S and several other national health care agencies. For more information, please visit Dr.Huber's website (www.ludwig-huber.com).

 
Deadline for Abstracts: 2015-10-13
 
Registration:

For more information about this event please visit

 

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1459

 

https://compliancetrainings.com/siteengine/Login.aspx

To register this webinar 

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.